Tanvir Khosla
Neurology · Phoenix, AZNPI 1861013815
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,255, 4.3 times the $295 reported in 2023.
Across 68 payments — averaging $30.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$352
- AstraZeneca$227
- Neurocrine Biosciences, Inc.$221
- Biogen$158
- Amgen$125
- Bayer$120
- plus $837 from 23 others
What the payments were for
- Food & beverage$2,040100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $352 |
| AstraZeneca | 2 | $227 |
| Neurocrine Biosciences, Inc. | 5 | $221 |
| Biogen | 4 | $158 |
| Amgen | 1 | $125 |
| Bayer | 1 | $120 |
| Amneal Pharmaceuticals LLC | 4 | $87 |
| Pfizer | 3 | $69 |
| C2n Diagnostics, LLC | 2 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| MDD US Operations, LLC | 3 | $56 |
| Acadia Pharmaceuticals Inc | 2 | $47 |
| Argenx US, Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $41 |
| Immedica Pharma US, Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Jazz Pharmaceuticals Inc. | 1 | $31 |
| Neurelis, Inc. | 1 | $27 |
| Eisai Inc. | 1 | $27 |
| Livanova USA, Inc. | 1 | $26 |
| TG Therapeutics, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| GE HealthCare | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| Grifols USA, LLC | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Octapharma USA, Inc. | 1 | $18 |
| Noctrix Health, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,040 in reported general payments places this provider in the 55th percentile of 388 neurology providers in Arizona.
Other neurology in Phoenix
- Barry HendinPhoenix$2.3M
- Maria OspinaPhoenix$2.1M
- Suraj MuleyPhoenix$1.7M
- Eric ErossPhoenix$778K
- Steve ChungPhoenix$685K
- Marwan SabbaghPhoenix$603K
- Kerry KnievelPhoenix$509K
- Lori TravisPhoenix$406K
- Jeffrey GittPhoenix$275K
- Todd SchwedtPhoenix$273K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.